Shenrui Jin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shenrui Jin has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Xuhua Qin
College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, 611137, China
9 shared publications Junyu Liu
School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China
6 shared publicationsYi Xu
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China
4 shared publicationsZulun Li
College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
4 shared publicationsChao He
College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China
2 shared publicationsTing Mao
College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China
2 shared publications
Latest Publications
- 18 October 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 356, 120761
Ardisia japonica (Thunb.) Blume: Traditional applications, phytochemistry, pharmacological activities, network pharmacology, and quality control
- 18 October 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 356, 120761
Ardisia japonica (Thunb.) Blume: Traditional applications, phytochemistry, pharmacological activities, network pharmacology, and quality control
- Open Access
- 11 August 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 303, 118828
Network toxicological mechanism analysis of pyrethroid insecticides-induced chronic respiratory system damage in humans
- 11 August 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 303, 118828
Open AccessNetwork toxicological mechanism analysis of pyrethroid insecticides-induced chronic respiratory system damage in humans
- Open Access
- 31 May 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (6) , 1355
The Potential of Matrine in the Treatment of Breast Cancer: A Review
Breast cancer ranks as the fifth-most-prevalent malignancy worldwide, characterized by high heterogeneity and multifactorial etiology across molecular subtypes. Despite advancements in conventional therapies, including surgery and chemotherapy, persistent challenges such as treatment-related adverse effects and acquired drug resistance necessitate alternative therapeutic strategies. Matrine, a naturally occurring alkaloid derived from Sophora flavescens, has demonstrated significant anticancer potential through multiple mechanisms. Experimental evidence indicates that matrine exerts inhibitory effects on tumor cell proliferation, promotes apoptosis, and attenuates metastatic progression via modulation of critical signaling pathways, particularly PI3K/Akt, JAK/STAT, NF-κB, MAPK/ERK, and Wnt/β-catenin. This review systematically examines subtype-specific responses to matrine treatment, highlighting its potential utility in precision oncology for distinct breast cancer classifications. Furthermore, we evaluate matrine’s capacity to synergize with standard chemotherapeutic regimens, potentially overcoming drug resistance while reducing required dosages. By integrating current preclinical and clinical findings, this analysis provides new perspectives on matrine’s therapeutic applications and underscores the imperative for translational studies to establish optimized treatment protocols for clinical implementation.
- 31 May 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (6) , 1355
Open AccessThe Potential of Matrine in the Treatment of Breast Cancer: A Review
Breast cancer ranks as the fifth-most-prevalent malignancy worldwide, characterized by high heterogeneity and multifactorial etiology across molecular subtypes. Despite advancements in conventional therapies, including surgery and chemotherapy, persistent challenges such as treatment-related adverse effects and acquired drug resistance necessitate alternative therapeutic strategies. Matrine, a naturally occurring alkaloid derived from Sophora flavescens, has demonstrated significant anticancer potential through multiple mechanisms. Experimental evidence indicates that matrine exerts inhibitory effects on tumor cell proliferation, promotes apoptosis, and attenuates metastatic progression via modulation of critical signaling pathways, particularly PI3K/Akt, JAK/STAT, NF-κB, MAPK/ERK, and Wnt/β-catenin. This review systematically examines subtype-specific responses to matrine treatment, highlighting its potential utility in precision oncology for distinct breast cancer classifications. Furthermore, we evaluate matrine’s capacity to synergize with standard chemotherapeutic regimens, potentially overcoming drug resistance while reducing required dosages. By integrating current preclinical and clinical findings, this analysis provides new perspectives on matrine’s therapeutic applications and underscores the imperative for translational studies to establish optimized treatment protocols for clinical implementation.
- Open Access
- 7 September 2022
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 974054
Chinese endemic medicinal plant Bolbostemma paniculatum (Maxim.) Franquet: A comprehensive review
Bolbostemma paniculatum (Maxim.) Franquet is a unique species in China with a long history of medicinal use, which has the effects of detoxifying, dissolving lumps and dispersing swellings. And it is commonly used to treat many diseases, such as carbuncle and sore, acute mastitis, mammary cancer, scrofula and subcutaneous nodule traditionally. Modern clinical studies have found that B. paniculatum and its compounds can be used for the treatment of a variety of cancers, mastitis, hyperplasia of mammary glands, chronic lymphadenitis, cervical lymph tuberculosis and surgical wart skin diseases, and the curative effect is positive. At present, a variety of Chinese patent medicines containing B. paniculatum have been exploited and marketed in China for the treatment of cancers, breast diseases and flat warts. This review article comprehensively discussed the traditional application, botany, chemical components, pharmacological activities, and quality control of B. paniculatum, put forward some noteworthy issues and suggestions in current studies, and briefly discussed the possible development potential of this plant as well as future research perspectives. 96 compounds have been isolated from B. paniculatum, including triterpenoids, sterols, alkaloids and other components, of which triterpenoid saponins are the main bioactive components. The crude extracts and monomer compounds of B. paniculatum have a wide range of pharmacological activities, such as anti-tumor, antiviral, anti-inflammatory, immunoregulatory, and so on. Moreover, its anti-tumor mechanism involves many aspects, including inhibiting cell proliferation, promoting cell apoptosis, blocking the cell cycle, interfering with cell invasion and metastasis, suppressing angiogenesis, and regulating autophagy. While there is a lack of systematic and in-depth research on its anti-tumor active components and mechanism of action at the moment; and a tight connection between the chemical composition and pharmacological activity of B. paniculatum has also not been established. Besides, a systematic quality determination standard for B. paniculatum should also be built, in order to carry out further research.
- 7 September 2022
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 974054
Open AccessChinese endemic medicinal plant Bolbostemma paniculatum (Maxim.) Franquet: A comprehensive review
Bolbostemma paniculatum (Maxim.) Franquet is a unique species in China with a long history of medicinal use, which has the effects of detoxifying, dissolving lumps and dispersing swellings. And it is commonly used to treat many diseases, such as carbuncle and sore, acute mastitis, mammary cancer, scrofula and subcutaneous nodule traditionally. Modern clinical studies have found that B. paniculatum and its compounds can be used for the treatment of a variety of cancers, mastitis, hyperplasia of mammary glands, chronic lymphadenitis, cervical lymph tuberculosis and surgical wart skin diseases, and the curative effect is positive. At present, a variety of Chinese patent medicines containing B. paniculatum have been exploited and marketed in China for the treatment of cancers, breast diseases and flat warts. This review article comprehensively discussed the traditional application, botany, chemical components, pharmacological activities, and quality control of B. paniculatum, put forward some noteworthy issues and suggestions in current studies, and briefly discussed the possible development potential of this plant as well as future research perspectives. 96 compounds have been isolated from B. paniculatum, including triterpenoids, sterols, alkaloids and other components, of which triterpenoid saponins are the main bioactive components. The crude extracts and monomer compounds of B. paniculatum have a wide range of pharmacological activities, such as anti-tumor, antiviral, anti-inflammatory, immunoregulatory, and so on. Moreover, its anti-tumor mechanism involves many aspects, including inhibiting cell proliferation, promoting cell apoptosis, blocking the cell cycle, interfering with cell invasion and metastasis, suppressing angiogenesis, and regulating autophagy. While there is a lack of systematic and in-depth research on its anti-tumor active components and mechanism of action at the moment; and a tight connection between the chemical composition and pharmacological activity of B. paniculatum has also not been established. Besides, a systematic quality determination standard for B. paniculatum should also be built, in order to carry out further research.
- 4 August 2022
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 298, 115584
Pyrolae herba: A review on its botany, traditional uses, phytochemistry, pharmacology and quality control
- 4 August 2022
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 298, 115584
Pyrolae herba: A review on its botany, traditional uses, phytochemistry, pharmacology and quality control
- 1 March 2022
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 285, 114907
Geranium wilfordii maxim.: A review of its traditional uses, phytochemistry, pharmacology, quality control and toxicology
- 1 March 2022
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 285, 114907
Geranium wilfordii maxim.: A review of its traditional uses, phytochemistry, pharmacology, quality control and toxicology
- 1 October 2021
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 279, 114357
A review of Cremastra appendiculata (D.Don) Makino as a traditional herbal medicine and its main components
- 1 October 2021
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 279, 114357
A review of Cremastra appendiculata (D.Don) Makino as a traditional herbal medicine and its main components
- Open Access
- 22 April 2021
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 12
The Traditional Uses, Phytochemistry and Pharmacology of Sarcandra glabra (Thunb.) Nakai, a Chinese Herb With Potential for Development: Review
Sarcandra glabra (Thunb.) Nakai is a folk medicine with a long history in China, which has been applied to treat sore throat, abscess, even tumor and so on. Meanwhile, it is also used as tea in some areas. At present, more than 200 chemical compounds have been isolated and identified from it, such as, sesquiterpenes, flavonoids, phenolic acids, coumarins and so on. Pharmacological studies have already confirmed that the extracts of S. glabra have many effects, such as antibacterial, antiviral, anti-inflammatory, anti-tumor, and anti-thrombocytopenia, especially the effects of anti-tumor and anti-thrombocytopenia are confirmed in clinic. Therefore, this paper systematically summarized the traditional uses, botany, phytochemistry, pharmacology, and toxicity of S. glabra, in order to provide a beneficial reference of its further research.
- 22 April 2021
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 12
Open AccessThe Traditional Uses, Phytochemistry and Pharmacology of Sarcandra glabra (Thunb.) Nakai, a Chinese Herb With Potential for Development: Review
Sarcandra glabra (Thunb.) Nakai is a folk medicine with a long history in China, which has been applied to treat sore throat, abscess, even tumor and so on. Meanwhile, it is also used as tea in some areas. At present, more than 200 chemical compounds have been isolated and identified from it, such as, sesquiterpenes, flavonoids, phenolic acids, coumarins and so on. Pharmacological studies have already confirmed that the extracts of S. glabra have many effects, such as antibacterial, antiviral, anti-inflammatory, anti-tumor, and anti-thrombocytopenia, especially the effects of anti-tumor and anti-thrombocytopenia are confirmed in clinic. Therefore, this paper systematically summarized the traditional uses, botany, phytochemistry, pharmacology, and toxicity of S. glabra, in order to provide a beneficial reference of its further research.
- Open Access
- 16 November 2020
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 11
Polygonumperfoliatum L., an Excellent Herbal Medicine Widely Used in China: A Review
Polygonum perfoliatum L. (synonym: Polygonum knotweed L.; Persicaria perfoliata; family: Polygonaceae) is a kind of folk traditional Chinese medicine with a long history of wide use in the treatment of ancient internal, surgical, and gynecological diseases. At present, 80 chemical constituents have been isolated from P. perfoliatum, including flavonoids, anthraquinones, terpenoids, phenolic acids, phenylpropanoids, and alkaloids, among which flavonoids are the main active components. Modern studies have shown that P. perfoliatum has pharmacological activities such as anti-inflammatory, anti-bacterial, antiviral, anti-liver fibrosis, antitussive and expectorant, anti-tumor, anti-oxidation, and so on. By consulting and sorting out a large number of related literatures at home and abroad in recent years, this paper systematically reviewed the botany, traditional uses, phytochemistry, pharmacological activities, and quality control of P. perfoliatum, and discussed its development potential in new drug research and clinical application in the future, in order to provide a reference basis for further research and promote the in-depth development and utilization.
- 16 November 2020
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 11
Open AccessPolygonumperfoliatum L., an Excellent Herbal Medicine Widely Used in China: A Review
Polygonum perfoliatum L. (synonym: Polygonum knotweed L.; Persicaria perfoliata; family: Polygonaceae) is a kind of folk traditional Chinese medicine with a long history of wide use in the treatment of ancient internal, surgical, and gynecological diseases. At present, 80 chemical constituents have been isolated from P. perfoliatum, including flavonoids, anthraquinones, terpenoids, phenolic acids, phenylpropanoids, and alkaloids, among which flavonoids are the main active components. Modern studies have shown that P. perfoliatum has pharmacological activities such as anti-inflammatory, anti-bacterial, antiviral, anti-liver fibrosis, antitussive and expectorant, anti-tumor, anti-oxidation, and so on. By consulting and sorting out a large number of related literatures at home and abroad in recent years, this paper systematically reviewed the botany, traditional uses, phytochemistry, pharmacological activities, and quality control of P. perfoliatum, and discussed its development potential in new drug research and clinical application in the future, in order to provide a reference basis for further research and promote the in-depth development and utilization.